| |
|
Form Serial Number: |
CS20240327E00251 |
| 1.
Date of relevant event: |
22/03/2024
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02186 |
| 4.
Name of listed corporation: |
Luye Pharma Group Ltd. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
3,761,670,643 |
| 7.
Name of substantial shareholder: |
UBS Group AG |
| 8.
Registered office: |
BAHNHOFSTRASSE 45 8001 ZURICH SWITZERLAND |
| 9.
Principal place of business in Hong Kong: |
52/F TWO INTERNATIONAL FINANCE CENTRE, 8 FINANCE STREET, CENTRAL, HONG KONG |
| 15.
Exchange on which listed: |
SIX Swiss Exchange AG |
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1104 | The percentage level of your interest in the shares has increased because:
you acquired a security interest in the shares |
|
|
| 2201 | Interest of corporation controlled by you |
|
742,500 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 488,819,092 | 12.99 |
| Short position | 351,951,364 | 9.36 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 489,561,592 | 13.01 |
| Short position | 351,951,364 | 9.36 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| | Long position | 489,561,592 | | Short position | 351,951,364 |
|
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| 4103 | Listed derivatives - Convertible instruments |
| | Long position | 169,327,369 | | Short position | 0 |
|
| 4105 | Unlisted derivatives - Physically settled |
| | Long position | 128,160,000 | | Short position | 128,160,000 |
|
| 4106 | Unlisted derivatives - Cash settled |
| | Long position | 61,662,750 | | Short position | 0 |
|
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| UBS Asset Management (Americas) LLC | Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, USA | UBS Group AG | 100.00 | Y | | Long position | 94,000 | | Short position | 0 |
|
| UBS Asset Management Switzerland AG | Bahnhofstrasse 45, Zurich, Switzerland | UBS Group AG | 100.00 | Y | | Long position | 543,000 | | Short position | 0 |
|
| UBS Fund Management (Switzerland) AG | Aeschenvorstadt 1 ,Basel ,Switzerland ,4051 | UBS Group AG | 100.00 | Y | | Long position | 447,000 | | Short position | 0 |
|
| UBS Asset Management (UK) Limited | 5 Broadgate, London, United Kingdom | UBS Group AG | 100.00 | Y | | Long position | 118,000 | | Short position | 0 |
|
| UBS Asset Management Life Limited | 5 Broadgate ,London ,United Kingdom ,EC2M 2QS | UBS Group AG | 100.00 | Y | | Long position | 41,000 | | Short position | 0 |
|
| UBS AG | Bahnhofstrasse 45, Zürich, Switzerland | UBS Group AG | 100.00 | Y | | Long position | 487,088,596 | | Short position | 351,951,364 |
|
| UBS Switzerland AG | Bahnhofstrasse 45, Zürich, Switzerland | UBS Group AG | 100.00 | Y | | Long position | 544,996 | | Short position | 0 |
|
| Credit Suisse Funds AG | Uetlibergstrasse 231, Zurich, 8045, Switzerland | UBS Group AG | 100.00 | Y | | Long position | 685,000 | | Short position | 0 |
|
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
218,500,000 of the reported long and short positions refer to the securities lending agreement executed in conjunction with the convertible bond issuance as disclosed on June 28 2023
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
27/03/2024
(dd/mm/yyyy)
|
|
|
|
|